SEC Form D · filed June 14, 2018
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Ursula Newman · London, United KingdomDirectorSever Totia · New York, NYDirectorJoseph M. Truluck · Charlottesville, VAExecRobertson H. Gilliland · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorJesse S. Jacobs · Playa Vista, CADirectorJames W. Newman, Jr · Charlottesville, VADirectorKweli Washington · New York, NYDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorMike Kerns · Playa Vista, CADirectorFred Ausubel · Allston, MAExecMatthew Tomich · New York, NYExec · DirectorThomas Scriven · Golden, CODirectorLauren Smith · Nashville, TNDirectorJames K. Anderson · Charlottesville, VADirectorJason Bergsman · Playa Vista, CADirectorPeter Feld · New York, NYDirectorCory Brown · Nashville, TNDirectorTony W. Goodman · Charlottesville, VADirectorW. C. Mccollum · Los Angeles, CAExecBankole A. Johnson · Charlottesville, VADirectorRonald Heffernan · Sandy, UTExec · DirectorMatthew Davis · Purcellville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗